Looking for reliable medications to treat 'Leishmaniasis'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.
Hosted on MSN4mon
Biopharma Bucking Market Trends on Positive FDA FeedbackThe treatment, ATI-1801, is a novel topical formulation of paromomycin (15% w/w) and is under advanced clinical development for treating cutaneous leishmaniasis, a disfiguring skin infection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results